Abali H, Yalcin S, Onal HC, Dane F, et al. A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study): A Turkish Oncology Group Am J Clin Oncol 2021;44:301-307.
PMID: 33979100